Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

1357

Actual shortage: 231 (17%)
Anticipated shortage: 0 (0%)
Avoided shortage: 1 (0%)
Resolved: 1125 (83%)

Discontinuation Reports

231

To be discontinued: 3 (1%)
Discontinued: 228 (99%)
Reversed: 0 (0%)

Late reports

235 (15%)

Overdue reports

3 (1%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT AMLODIPINE 2.5MG TABLET Resolved 2017-03-17 2017-09-19 3348
ACT AMLODIPINE 5MG TABLET Resolved 2020-11-06 2021-01-07 127998
ACT AMLODIPINE 10MG TABLET Resolved 2020-11-06 2021-01-21 128034
ACT AMPHETAMINE XR 3.75MG 3.75MG 3.75MG 3.75MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60068
ACT AMPHETAMINE XR 5MG 5MG 5MG 5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60075
ACT AMPHETAMINE XR 6.25MG 6.25MG 6.25MG 6.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61330
ACT AMPHETAMINE XR 7.5MG 7.5MG 7.5MG 7.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61333
ACT AMPHETAMINE XR 1.25MG 1.25MG 1.25MG 1.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61336
ACT AMPHETAMINE XR 2.5MG 2.5MG 2.5MG 2.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-11-30 2019-01-31 68265
ACT AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Actual shortage 2021-01-15 2021-02-18 131676
ACT AMPHETAMINE XR 15MG CAPSULE (EXTENDED RELEASE) Actual shortage 2021-01-15 2021-02-18 131679
TEVA-ANASTROZOLE 1MG TABLET Resolved 2020-01-24 2021-01-28 104374
ACT BORTEZOMIB 3.5MG POWDER FOR SOLUTION Resolved 2020-01-30 2020-05-29 104930
ACT BORTEZOMIB 3.5MG POWDER FOR SOLUTION Resolved 2020-09-25 2020-10-22 125031
ACT BUPRENORPHINE/NALOXONE 8MG 2MG TABLET Resolved 2019-09-26 2020-01-24 94896
ACT BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2019-10-03 2020-01-24 95396
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-17 68569
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-10 68572
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2020-02-13 68577
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-11-22 68580

Showing 1 to 20 of 1357

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-TRIMEL 400MG 80MG TABLET Discontinued 2018-10-19 2018-10-19 65017
TEVA-TRIMEL 400MG 80MG TABLET Discontinued 2020-02-13 2020-02-13 106133
TEVA-TRIMEL DS 800MG 160MG TABLET Discontinued 2018-10-19 2018-10-19 65020
TEVA-TRIMEL DS 800MG 160MG TABLET Discontinued 2018-10-19 2018-10-19 65023
TEVA-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-02-07 2020-02-08 105537
TEVA-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-06-11 2020-06-11 117546
TEVA-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-09-24 2020-09-24 124899
VINORELBINE TARTRATE FOR INJECTION 10MG SOLUTION To be discontinued 2019-07-05 2019-07-05 88619
VINORELBINE TARTRATE FOR INJECTION 10MG SOLUTION Discontinued 2019-09-27 2019-10-01 94980
VINORELBINE TARTRATE FOR INJECTION 10MG SOLUTION Discontinued 2019-10-17 2019-10-17 96695
ZOLEDRONIC ACID INJECTION 5MG SOLUTION Discontinued 2017-06-27 2017-06-27 14030

Showing 221 to 231 of 231